• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number ETBF3616C145E
Device Problems Leak/Splash (1354); Separation Failure (2547); Folded (2630)
Patient Problem Injury (2348)
Event Date 12/06/2014
Event Type  Injury  
Event Description
An endurant ii stent graft system was implanted for treatment of an abdominal aortic aneurysm.Proximal neck measure 29, 30, 32, and 33 and was about 15mm in length.It was reported that the patient presented emergently with abdominal pain and a ruptured aneurysm.After the stent grafts were implanted, on final angiogram a type i endoleak was noted.Re-ballooned with the coda balloon, while the type i endoleak looked better, it was still apparent.However, the physician decided to leave it.The patient went to pacu and was still complaining of pain.A ct was completed and analyzed to identify a pleat in the graft from the very top of the fabric distally causing the type i endoleak.Upon further analysis using tera recon, the physician could see the two right posterior supra renal stents were intertwined.The physician brought the patient back into the or with a plan to figure out exactly what was going on and determine a plan of action.Using ivus, he could see the pleat from the top of the fabric was about 35mm in length landing about 15mm above the flow divider.The physician tried to use a balloon first and manipulate the joined sr stents using that balloon.That was unsuccessful.The next step was to aptus staples at the right posterior quadrant using 17 aptus staples.While the leak appeared better, is was not resolved.A 10/50 palmaz stent was mounted on a 30mm balloon and deployed successfully.The palmaz was then ballooned to fully expand it to the 36mm diameter of the graft.The final angiogram still showed a leak.The patient tolerated the procedure.The patient still had quite a palpable aortic pulse and was symptomatic coming in to yesterday's follow up case.The following day another ct was done noting that the type i endoleak has shrunk, the pain has gone away for the most part and the patient was discharged.The physician is monitoring the patient.No additional clinical sequelae were reported.A review of several returned films.Review of a 9 second video from a cta study (unknown date) showed that the aortic body appeared to have infolded.There was also a possible suprarenal stent entanglement; however, this was difficult to confirm since the video did not show the entire suprarenal stents.The ipsilateral limb was positioned within the right iliac, and the contra limb into the left iliac.There was a likely proximal type i endoleak.Another 18 second video during angiogram procedure (unknown study date) revealed that multiple aptus staples had been placed into the proximal 2cm¿s of the bifurcate along the right wall of the aorta.A palmaz stent was also visible within the aortic body extending to slightly above the proximal stent graft margin.An endoleak was seen; possibly a proximal type i.The proximal stent graft od measured approximately 22mm, and the aortic neck appeared relatively straight l-r.A single still cta 3d recon image showed that 2 adjacent suprarenal stents appeared to have entangled.The cause of the proximal type i endoleak was likely due to the suprarenal stent entanglement, which caused a section of the aortic body fabric to infold.Images during the implant procedure were not available for return.The cause of the entanglement could not be determined from these images.
 
Manufacturer Narrative
(b)(4).Evaluation, conclusions: off-label, unapproved, or contraindicated use (pre-operative rupture).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC CARDIOVASCULAR
3576 unocal place
santa rosa CA 95403
Manufacturer Contact
eric elliott
3576 unocal place
santa rosa, CA 95403
7075912586
MDR Report Key4361703
MDR Text Key21555930
Report Number2953200-2014-02755
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/06/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/12/2016
Device Catalogue NumberETBF3616C145E
Device Lot NumberV05906095
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/06/2014
Initial Date FDA Received12/24/2014
Date Device Manufactured08/13/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00090 YR
-
-